“Our ultimate goal is to prevent strokes," one Mayo Clinic electrophysiologist said. "I believe the current study has brought us one step closer.”

The recall is due to a malfunction risk that could, if not handled properly, cause the pump to stop working for a long period of time. This could lead to a serious injury or death, according to the recall. 

Monique Rasband, vice president of imaging, cardiology and oncology, KLAS Research, explains a few of the key technology trends in cardiovascular information systems (CVIS).

Patients face a risk of adverse events if they mistakenly take the wrong medication, according to a new warning from the FDA. 

If researchers can find ways to prevent AKI after TAVR, it could help decrease the risk of poor outcomes in more ways than one. 

The PROTECTED TAVR results presented at TCT 2022 resulted in a mix of reactions. For some cardiologists, the slight reduction in the risk of a disabling stroke after TAVR is a positive result. For others, it was simply not enough. 

Results from the Medtronic SYMPLICITY HTN-3 trial long-term results and the pivotal RADIANCE II trial for the Recor ultrasound renal denervation system lowered blood pressure effectively in drug-resistant patients.

Optum has completed its nearly $8 billion merger with Change Healthcare, bringing an end to an embattled and controversial transaction.